Hemoglobin A0 and α-crosslinked hemoglobin (α-DBBF) potentiate agonist-induced platelet aggregation through the platelet thromboxane receptor

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 26, Issue 1, 1998, Pages 1-16

  Mondoro, Traci Heath ^a   Alayash, Abdu I ^a   Brockner Ryan, Beth A ^a   Terle, Douglas A ^a   Vostal, Jaroslav G ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; CROSSLINKING; HEMOGLOBIN;

ARACHIDONIC ACID; PLATELETS;

BLOOD SUBSTITUTES;

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; HEMOGLOBIN A; HEMOGLOBIN DERIVATIVE; SEROTONIN; THROMBOXANE RECEPTOR; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLSALICYLIC ACID; BIS(3,5 DIBROMOSALICYL)FUMARATE CROSSLINKED HEMOGLOBIN A(0); BIS(3,5-DIBROMOSALICYL)FUMARATE-CROSSLINKED HEMOGLOBIN A(0); BLOOD SUBSTITUTE; COLLAGEN; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; HEME; HEMOGLOBIN A(0); MEMBRANE PROTEIN; PROSTAGLANDIN RECEPTOR; THROMBIN; THROMBOXANE A2 RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; SEROTONIN RELEASE; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; BLOOD; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; SECOND MESSENGER; THROMBOCYTE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; BLOOD SUBSTITUTES; COLLAGEN; DRUG SYNERGISM; HEME; HEMOGLOBIN A; HUMANS; MEMBRANE PROTEINS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SECOND MESSENGER SYSTEMS; THROMBIN;

EID: 0031594774     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199809118942     Document Type: Article

References (40)

1. Winslow RM. Hemoglobin-based Red Cell Substitutes. Johns Hopkins University Press, Baltimore, MD pp 136-163 (1992).
2. Hess JR, MacDonald VW, Brinkely WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 74:1769-1778 (1993).
3. Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Cashon RE. Nitric oxide binding to human ferrihemoglobins cross-linked between either alpha or beta subunits. Arch Biochem Biophys 303:332-338 (1993).
4. α2) J Biol Chem 261:9929-9937 (1986).
5. Ranney HM, Sharma V. Structure and function of hemoglobin. In: Williams Hematology. Beutler E, Lichtman MA, Coller BS, Kipps TJ eds. McGraw Hill, New York, NY pp 417-425 (1995).
6. 0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferry 1 intermediate. Arch Biochem Biophys 316:461-469 (1995).
7. Puppo A, Halliwell B. Formation of hydroxyl radicals in biological systems: Does myoglobin stimulate hydroxyl radical formation? Free Radic Res Commun 4:415-422 (1988).
8. Faasen AE, Sundby R, Panter SS, Condie RM, Hedlund BE. Hemoglobin: A lifesaver and an oxidant. How to tip the balance. Biomat Art Cells Art Org 16:93-104 (1988).
9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142 (1989).
10. Alayash AI, Fratantoni JC, Bonaventura C, Bonaventura J, Bucci E. Consequences of chemical modifications on the free radical reactions of human hemoglobin. Arch Biochem Biophys 298:114-120 (1992).
11. Bolin R, Smith D, Moore G, Boswell G, DeVenuto F. Hematologic effects of hemoglobin solutions in animals. Prog Clin Biol Res 122:117-126 (1983).
12. White CT, Murray AJ, Greene JR, Smith DJ, Medina F, Makovec GT, Martin EJ, Bolin RB. Toxicity of human hemoglobin solution infused into rabbits. J Lab Clin Med 108:121-131 (1986).
13. Iuliano L, Violi F, Pedersen JZ, Pratico D, Rotilio G, Balsano F. Free radicalmediated platelet acitvation by hemoglobin released from red blood cells. Arch Biochem Biophys 299:220-224 (1992).
14. Olsen SB, Tang DB, Jackson MR, Gomez ER, Ayala B, Alving BM. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 93:327-332 (1996).
15. Nakashima S, Tohmatsu T, Hattori H, Okano Y, Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis, and calcium mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Comm 135:1099-1104 (1986).
16. 0 for possible use as a blood substitute. J Biochem Biophys Meth 17:143-154 (1988).
17. Snyder, SR, Welty EV, Walder RY, Williams LA, Walder JA, HbXL99 alpha: A hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc Natl Acad Sci USA 84:7280-7284 (1987).
18. Di Iorio EE. Preparation of derivatives of ferrous and ferric hemoglobin. Methods Enzymol 76:57-72 (1981).
19. Fratantoni JC, Poindexter BJ. Measuring platelet aggregation with a microplate reader: A new technical approach to platelet aggregation studies. Am J Clin Pathol 94:613-617 (1993).
20. Thé TH, Feltkamp TEW. Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunol 18:875-81 (1970).
21. Faraday, N, Goldschrnidt-Clermont, P, Dise, K, and Bray, PF. Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry. J Lab Clin Med 123:728-740 (1994).
22. Bundy GL. The synthesis of prostaglandin endoperoxide analogs. Tetrahedron Lett 24:1957-1960 (1975).
23. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929 (1962).
24. Dickerson RE, Geis I. Hemoglobin: Structure, Function, Evolution and Pathology. Benjamin/Cummings Publishing, Menlo Park, CA pp 66-72 (1983).
25. Rao GHR, White JG. Disaggregation and reaggregation of "irreversibly" aggregated platelets: A method for more complete evaluation of anti-platelet drugs. Agents Actions 16:425-433 (1985).
26. Goldberg MR, Robertson D. Yohimbine: A pharmacological probe for study of the alpha 2-αdrenoreceptor. Pharmacol Rev 35:143-180 (1983).
27. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 69:58-178 (1989).
28. 3H)arachidonate from human platelets stimulated by thrombin or collagen. Thromb Haemost 72:634-642 (1994).
29. Lapetina EG. The signal transduction induced by thrombin in human platelets. FEBS Lett 268:400-404 (1990).
30. 2 in collagen-stimulated human platelets. Biochem J 289:641-646 (1993).
31. Darius H, Smith JB, Lefer AM. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. J Pharmacol Exp Ther 235:274-281 (1985).
32. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64:1393-1401 (1979).
33. Kieffer N, Phillips DR. Platelet membrane glycoproteins: Functions in cellular interactions. Ann Rev Cell Bio 6:329-357 (1990).
34. Korn ED. Biochemistry of actomyosin-dependent cell motility. Proc. Natl. Acad. Sci. USA 1978; 75:588-599 (1978).
35. Fox JEB. The platelet cytoskeleton. Thromb Haemost 70:884-893 (1993).
36. Savitsky JP, Doczi J, Black J, Arnold JD. A clinical safety trial of stromafree hemoglobin. Clin Pharmacol Ther 23:73-80 (1978).
37. Zilletti L, Ciuffi M, Franchi-Micheli S, Fusi F, Gentilini G, Moneti G, Valoti M, Sgaragli GP. Cyclooxygenäse activity of hemoglobin. Methods Enzymol 231:562-573 (1994).
38. Kühn H, Götze R, Schewe T, Rapoport SM. Quasi-lipoxygenase activity of haemoglobin: A model for lipoxygenases. Eur J Biochem 120:161-168 (1981).
39. Rioux F, Drapeau G, Audet R, Burhop KE, Marceau F. Mechanism of the contractile effect of diaspirin-cross-linked hemoglobin in rat isolated aorta strip denuded of endothelium as revealed using an oil-immersion procedure. Can J Physiol Pharmacol 74:1171-1179 (1996).
40. 3 (platelet GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interactions. J Clin Invest 88:1128-1134 (1991).